04/03/2021 2:49 am Welcome to isteroids.com - BLOG

Tuesday 22, Jun 2010

  Drug combination effective to treat patients with multiple myeloma

Posted By
Pin it Share on Tumblr

Drug combination effective to treat patients with multiple myelomaDuring a study conducted at 44 centers in the United States and Canada and involving 353 patients with myeloma, it was found that a combination of drugs lenalidomide and dexamethasone could be useful for treating patients.

It was found during the study that pairing a new derivative of thalidomide with a steroid could slow down the progress of multiple myeloma along with prolonging lives of patients who have earlier relapsed from past treatments.

It was remarked by lead author Donna Weber, M.D., associate professor in the Department of Lymphoma and Myeloma at the University of Texas M. D. Anderson Cancer Center that these combinational drugs are effective as the disease may become immune to one therapy.

Tuesday 16, Feb 2010

  Lenalidomide and Dexamethasone combination useful for treating multiple myeloma patients

Posted By
Pin it Share on Tumblr

Lenalidomide and Dexamethasone combination useful for treating multiple myeloma patientsMultiple myeloma can be effectively treated by using a combination of lenalidomide and dexamethasone, according to a study that involved 353 patients with myeloma and conducted at 44 centers in the United States and Canada.

It was revealed during the study that pairing a new thalidomide derivative with a steroid can slow down the progression of multiple myeloma besides prolonging the lives of patients who have relapsed from earlier treatments.

Lead author Donna Weber, M.D., associate professor in the Department of Lymphoma and Myeloma at The University of Texas M. D. Anderson Cancer Center, said that the combination seems to be effective as the disease may become immune to one therapy.

Wednesday 02, Sep 2009

  Lenalidomide and dexamethasone effectual against multiple myeloma

Posted By
Pin it Share on Tumblr

Lenalidomide and dexamethasone effectual against multiple myeloma The combination of lenalidomide and dexamethasone is effectual against multiple myeloma: this was a fact that was revealed after a study involving 353 patients with myeloma was conducted at 44 centers in the United States and Canada.

The study also found out that pairing a new thalidomide derivative with a steroid can considerably slowdown any further progression of multiple myeloma, which is an incurable bone marrow cancer. It was also revealed that this combination may also prove its worth to prolong lives of patients who have relapsed from previous treatments.

It was remarked by lead author Donna Weber, M.D., Associate Professor in the Department of Lymphoma and Myeloma at The University of Texas M. D. Anderson Cancer Center that a combination of medical drugs may prove to be beneficial in ongoing treatment as a disease may become resistant to one drug.

Sunday 19, Jul 2009

  Thalomid offers hope for blood cancer patients

Posted By
Pin it Share on Tumblr

Thalomid offers hope for blood cancer patientsThalomid, which is also known as thalidomide, has been halted by drug company Celgene earlier than expected after the drug was shown to limit the progression of the blood cancer multiple myeloma.

It was revealed during the phase 3 trial of 270 patients that thalomid offers great benefits to patients who are suffering from blood cancer. These results prompted the decision that the trial patients not on this drug should also be given an opportunity to add thalomid to their treatment regimen.

Celgene has also recently sought approval from the FDA for Revlimid for the treatment of last-stage multiple myeloma.